Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients
SARS-CoV-2 vaccines are safe and immunogenic in most people with cancer, according to study
10 November 2021Supportive strategies help ‘picky eaters’ deal with food aversions
11 November 2021Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients
A world-first scientific study, published in the New England Journal of Medicine, has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits across the NHS.
